Summary: H.R.1271 — 115th Congress (2017-2018)All Information (Except Text)

There is one summary for H.R.1271. Bill summaries are authored by CRS.

Shown Here:
Introduced in House (03/01/2017)

DXM Abuse Prevention Act of 2017

This bill amends the Federal Food, Drug, and Cosmetic Act to: (1) require a retailer that sells certain drugs containing dextromethorphan (DXM) to have a verification system that is intended to ensure that no one under 18 years of age purchases such drugs from the retailer, (2) establish other restrictions on the sale of over-the-counter drugs containing DXM, and (3) establish restrictions on the distribution of bulk DXM.